Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-15

Clinical Trial Update: Retapamulin Microdialysis Feasibility Study [Phase 1]

View source ↗

Summary

Phase 1 microdialysis feasibility study of retapamulin for bacterial skin infections has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Altabax (retapamulin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Skin Infections, Bacterial | Phase 1 | Status: COMPLETED